The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults
Open accessAbstract
OBJECTIVE: To assess cross-sectional associations of neurofibrillary tangles, measured by tau-PET, with cognitive performance in cognitively unimpaired (CU) adults. METHODS: Tau- and amyloid-PET were performed in 579 CU participants aged 50-98 from the population-based Mayo Clinic Study of Aging. Associations between tau-PET signal in 43 brain regions and cognitive test scores were assessed using penalized linear regression. In additional models, participants were classified by normal/abnormal global amyloid-PET (A+/A-) and normal/abnormal regional tau-PET (T+/T-). Regional tau-PET cutpoints were defined as standardized uptake value ratio (SUVR) greater than the 95th percentile of tau-PET SUVR in that region among 117 CU participants aged 30-49. RESULTS: scores was seen in the entorhinal cortex; this association was independent of tau-PET signal in other brain regions. Tau-PET in the entorhinal cortex was also associated with poorer global and language performance. In the entorhinal cortex, T+ was associated with lower memory performance among both A- and A+. CONCLUSIONS: Tau deposition in MTL regions, as reflected by tau-PET signal, was associated with poorer performance on memory tests in CU participants. The association with entorhinal cortex tau-PET was independent of tau-PET signal in other brain regions. Longitudinal studies are needed to understand the fate of CU participants with elevated medial temporal tau-PET signal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“it has become evident that it is the spread of NFT pathology that correlates best, and possibly causes, substantial cognitive impairment in AD”
From The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics (2022) · cites this paper as [20]
In the citing paper
“The NFT tau PET signal was significantly associated with impairment of various measures of cognition, on a region-of-interest basis.When the NFT tau PET signal was stratified by amyloid status, there was no significant evidence that amyloid modified the effect of the NFT tau PET signal.”
From The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics (2022) · cites this paper as [20]
In the citing paper
“In a cross-sectional study, Lowe et al. 20 studied the association of neurofibrillary (NFT) tau PET and Aβ PET on cognition in 579 cognitively unimpaired adults.The participants' median age was 70 and abnormal NFT tau PET, defined as a signal in the entorhinal region, was seen in 20%, while abnormal Aβ was seen in 34% of the cohort.”
From The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics (2022) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Self-citationNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 4×
“The gold standard of AD diagnosis relies on autopsy data quantifying Aβ and NFT load throughout the brain.(3) The relationship of cognitive decline to these pathologies as seen at autopsy is well-described(4,5); however, the relationship of cognitive decline and these 2 pathologies early in the disease process is not…”
MethodResultInfluentialAlbert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152 · cited 1×
“Amyloid-PET can identify Aβ plaques and is an important tool for understanding AD pathogenisis.(11,12) Tau-PET using AV-1451 identifies AD NFT burden throughout disease progression.”
MethodSelf-citationAvants, B., Epstein, C. L., Grossman, M., & Gee, J. C. (2007) · Medical Image Analysis · doi:10.1016/j.media.2007.06.004 · Cited by 5,924
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Albert, M., DeKosky, S. T., Dickson, D. W., Dubois, B., Feldman, H., Fox, N. C., Gamst, A. C., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.1.96 · Cited by 2,643
Self-citationNelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050
Abstract reward and punishment representations in the human orbitofrontal cortex
O'Doherty, J., Kringelbach, M. L., Rolls, E. T., Hornak, J., & Andrews, C. (2001) · Nature Neuroscience · doi:10.1038/82959 · Cited by 2,003
Scheltens, P., Leys, D., Barkhof, F., Huglo, D. G., Weinstein, H. C., Vermersch, P., Kuiper, M. A., Steinling, M., Wolters, E. C., & Valk, J. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.10.967 · Cited by 1,816
Primary age-related tauopathy (PART): a common pathology associated with human aging
Crary, J. F., Trojanowski, J. Q., Schneider, J. A., Abisambra, J. F., Abner, E. L., Alafuzoff, I., Arnold, S. E., Attems, J., Beach, T. G., Bigio, E. H., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1349-0 · Cited by 1,467
Self-citation
Cited by
Sorted by citations
The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics
Karran, E., & De Strooper, B. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00391-w · Cited by 742
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
Vogel, J. W., Iturria‐Medina, Y., Strandberg, O. T., Smith, R. A., Levitis, E., Evans, A. C., Hansson, O., Initiative, A. D. N., Weiner, M. W., Aisen, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15701-2 · Cited by 537
Self-citationSanchez, J. S., Becker, J. A., Jacobs, H. I. L., Hanseeuw, B. J., Jiang, S., Schultz, A. P., Properzi, M. J., Katz, S. R., Beiser, A., Satizabal, C. L., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc0655 · Cited by 200
Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age
Betthauser, T. J., Koscik, R. L., Jonaitis, E. M., Allison, S. L., Cody, K. A., Erickson, C. M., Rowley, H. A., Stone, C. K., Mueller, K. D., Clark, L. R., et al. (2019) · Brain · doi:10.1093/brain/awz378 · Cited by 176
Limorenko, G., & Lashuel, H. A. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00127b · Cited by 168
Entorhinal cortex tau, amyloid-β, cortical thickness and memory performance in non-demented subjects
Knopman, D. S., Lundt, E. S., Therneau, T. M., Vemuri, P., Lowe, V. J., Kantarci, K., Gunter, J. L., Senjem, M. L., Mielke, M. M., Machulda, M. M., et al. (2019) · Brain · doi:10.1093/brain/awz025 · Cited by 104
Self-citationTherriault, J., Pascoal, T. A., Benedet, A. L., Tissot, C., Savard, M., Chamoun, M., Lussier, F., Kang, M. S., Berzgin, G., Wang, T., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011416 · Cited by 91
Young, C. B., Winer, J. R., Younes, K., Cody, K. A., Betthauser, T. J., Johnson, S. C., Schultz, A., Sperling, R. A., Greicius, M. D., Cobos, I., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.0676 · Cited by 79
Self-citationAPOE effects on regional tau in preclinical Alzheimer’s disease
Young, C. B., Johns, E., Kennedy, G., Belloy, M. E., Insel, P. S., Greicius, M. D., Sperling, R. A., Johnson, K. A., Poston, K. L., Mormino, E. C., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00590-4 · Cited by 80
Anosmia, mild cognitive impairment, and biomarkers of brain aging in older adults
Dong, Y., Li, Y., Liu, K., Han, X., Liu, R., Ren, Y., Cong, L., Zhang, Q., Hou, T., Song, L., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12777 · Cited by 74
Ramanan, V. K., Castillo, A. M., Knopman, D. S., Graff‐Radford, J., Lowe, V. J., Petersen, R. C., Jack, C. R., Mielke, M. M., & Vemuri, P. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.13909 · Cited by 74
Self-citationStaging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
Chen, S.-D., Lu, J.-Y., Li, H.-Q., Yang, Y.-X., Jiang, J.-H., Cui, M., Zuo, C.-T., Tan, L., Dong, Q., Yu, J.-T., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01602-5 · Cited by 71
Self-citationKnopman, D. S., Lundt, E. S., Therneau, T. M., Albertson, S. M., Gunter, J. L., Senjem, M. L., Schwarz, C. G., Mielke, M. M., Machulda, M. M., Boeve, B. F., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2020.3921 · Cited by 61
Self-citationDementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks
Schumacher, J., Gunter, J. L., Przybelski, S. A., Jones, D. T., Graff‐Radford, J., Savica, R., Schwarz, C. G., Senjem, M. L., Jack, C. R., Lowe, V. J., et al. (2021) · Brain · doi:10.1093/brain/awab218 · Cited by 57
Self-citationLu, M., Pontecorvo, M. J., Devous, M. D., Arora, A. K., Galante, N., McGeehan, A., Devadanam, C., Salloway, S. P., Doraiswamy, P. M., Curtis, C., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2020.5505 · Cited by 56
Association of β-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition
Tideman, P., Stomrud, E., Leuzy, A., Mattsson, N., Palmqvist, S., Hansson, O., & Initiative, A. D. N. (2022) · Neurology · doi:10.1212/wnl.0000000000013299 · Cited by 54
Age-related and amyloid-beta-independent tau deposition and its downstream effects
Wuestefeld, A., Binette, A. P., Berron, D., Spotorno, N., van Westen, D., Stomrud, E., Mattsson, N., Strandberg, O. T., Smith, R. A., Palmqvist, S., et al. (2023) · Brain · doi:10.1093/brain/awad135 · Cited by 58
Therriault, J., Pascoal, T. A., Savard, M., Benedet, A. L., Chamoun, M., Tissot, C., Lussier, F. Z., Kang, M. S., Thomas, E. M., Terada, T., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000011081 · Cited by 53
What’s the cut-point?: a systematic investigation of tau PET thresholding methods
Weigand, A. J., Maaß, A., Eglit, G. L., & Bondi, M. W. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00986-w · Cited by 49
Witnessed apneas are associated with elevated tau-PET levels in cognitively unimpaired elderly
Carvalho, D. Z., Louis, E. K. S., Schwarz, C. G., Lowe, V. J., Boeve, B. F., Przybelski, S. A., Reddy, A., Mielke, M. M., Knopman, D. S., Petersen, R. C., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009315 · Cited by 41
Self-citationSchwarz, C. G., Therneau, T. M., Weigand, S. D., Gunter, J. L., Lowe, V. J., Przybelski, S. A., Senjem, M. L., Botha, H., Vemuri, P., Kantarci, K., et al. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118259 · Cited by 42
Self-citationInitiative, A. D. N., Ramanan, V. K., Lesnick, T. G., Przybelski, S. A., Heckman, M. G., Knopman, D. S., Graff‐Radford, J., Lowe, V. J., Machulda, M. M., Mielke, M. M., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01154-1 · Cited by 40
Self-citationRelationships between β-amyloid and tau in an elderly population: An accelerated failure time model
Therneau, T. M., Knopman, D. S., Lowe, V. J., Botha, H., Graff‐Radford, J., Jones, D. T., Vemuri, P., Mielke, M. M., Schwarz, C. G., Senjem, M. L., et al. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118440 · Cited by 36
Self-citationNew therapies on the horizon: Targeted protein degradation in neuroscience
Gregory, J. A., Hickey, C. M., Chavez, J. D., & Cacace, A. M. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.08.010 · Cited by 42
Ghisays, V., Goradia, D. D., Protas, H. D., Bauer, R. J., III, Devadas, V., Tariot, P. N., Lowe, V. J., Knopman, D. S., Petersen, R. C., Jack, C. R., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.08.195 · Cited by 35
Self-citationAmyloid and Tau PET Imaging of Alzheimer Disease and Other Neurodegenerative Conditions
Rowley, P. A., Samsonov, A. A., Betthauser, T. J., Pirasteh, A., Johnson, S. C., & Eisenmenger, L. B. (2020) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2020.08.011 · Cited by 40
A golden age of muscarinic acetylcholine receptor modulation in neurological diseases
Tobin, A. B. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01007-1 · Cited by 38
Burnham, S. C., Iaccarino, L., Pontecorvo, M. J., Fleisher, A., Lu, M., Collins, E. C., & Devous, M. D. (2023) · Brain Communications · doi:10.1093/braincomms/fcad305 · Cited by 30
Seo, E. H., Lim, H. J., Yoon, H., Choi, K. Y., Lee, J. J., Park, J. Y., Choi, S. H., Kim, H., Kim, B. C., & Lee, K. H. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00909-1 · Cited by 26
Variants inPPP2R2BandIGF2BP3are associated with higher tau deposition
Ramanan, V. K., Wang, X., Przybelski, S. A., Raghavan, S., Heckman, M. G., Batzler, A. J., Kosel, M., Hohman, T. J., Knopman, D. S., Graff‐Radford, J., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa159 · Cited by 23
Self-citationImplication of tau propagation on neurodegeneration in Alzheimer’s disease
Lamontagne-Kam, D., Ulfat, A. K., Hervé, V., Vu, T.-M., & Brouillette, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1219299 · Cited by 28
Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis
Zeydan, B., Lowe, V. J., Reichard, R. R., Przybelski, S. A., Lesnick, T. G., Schwarz, C. G., Senjem, M. L., Gunter, J. L., Parisi, J. E., Machulda, M. M., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25684 · Cited by 27
Self-citationGenetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis
Ramanan, V. K., Gebre, R. K., Graff-Radford, J., Hofrenning, E., Algeciras-Schimnich, A., Figdore, D. J., Lowe, V. J., Mielke, M. M., Knopman, D. S., Ross, O. A., et al. (2023) · Brain · doi:10.1093/brain/awad196 · Cited by 24
Self-citationTau accumulation and atrophy predict amyloid independent cognitive decline in aging
Fonseca, C. S., Baker, S. L., Dobyns, L., Janabi, M., Jagust, W. J., & Harrison, T. M. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13654 · Cited by 25
The current status and challenges of olfactory dysfunction study in Alzheimer's Disease
Liao, W., Wang, Y., Wang, L., Li, J., Huang, D., Cheng, W., & Luan, P. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102453 · Cited by 23
Aschenbrenner, A. J., Gordon, B. A., Fagan, A. M., Schindler, S. E., Balota, D. A., Morris, J. C., & Hassenstab, J. J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200018 · Cited by 23
Genetically identical twins show comparable tau PET load and spatial distribution
Coomans, E. M., Tomassen, J., Ossenkoppele, R., Golla, S. S. V., den Hollander, M. E., Collij, L. E., Weltings, E., van der Landen, S. M., Wolters, E. E., Windhorst, A. D., et al. (2022) · Brain · doi:10.1093/brain/awac004 · Cited by 23
Tsoy, E., Strom, A., Iaccarino, L., Erlhoff, S. J., Goode, C. A., Rodriguez, A.-M., Rabinovici, G. D., Miller, B. L., Kramer, J. H., Rankin, K. P., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00776-w · Cited by 23
Episodic Memory Impairment Mediates the Loss of Awareness in Mild Cognitive Impairment
Gagliardi, G. P., & Vannini, P. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.802501 · Cited by 21
Pelgrim, T. A. D., Beran, M., Twait, E. L., Geerlings, M. I., & Vonk, J. M. J. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101449 · Cited by 21
Mesial temporal tau in amyloid-β-negative cognitively normal older persons
Krishnadas, N., Doré, V., Groot, C., Lamb, F., Bourgeat, P., Burnham, S. C., Huang, K., Goh, A., Masters, C. L., Villemagne, V. L., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00993-x · Cited by 23
Hippocampal subfield associations with memory depend on stimulus modality and retrieval mode
Aumont, É., Bussy, A., Bédard, M., Bezgin, G., Therriault, J., Savard, M., Arias, J. F., Sziklas, V., Vitali, P., Poltronetti, N. M., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad309 · Cited by 23
Young, C. B., Mormino, E. C., Poston, K. L., Johnson, K. A., Rentz, D. M., Sperling, R. A., & Papp, K. V. (2023) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12414 · Cited by 18
Amyloid PET detects the deposition of brain Aβ earlier than CSF fluid biomarkers
Lowe, V. J., Mester, C. T., Lundt, E. S., Lee, J., Ghatamaneni, S., Algeciras‐Schimnich, A., Campbell, M. R., Graff‐Radford, J., Nguyen, A. T., Min, H.-K. P., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14317 · Cited by 20
Self-citationMoscoso, A., Grothe, M. J., Schöll, M., & Initiative, A. D. N. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05195-5 · Cited by 16
Therapeutic effects of total saikosaponins from Radix bupleuri against Alzheimer’s disease
Li, J., Zou, B., Cheng, X.-Y., Yang, X.-H., Li, J., Zhao, C.-H., Ma, R., Tian, J., & Yao, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.940999 · Cited by 16
Boots, E. A., Frank, R. D., Fan, W. Z., Christianson, T. J. H., Kremers, W. K., Stricker, J. L., Machulda, M. M., Fields, J. A., Hassenstab, J. J., Graff-Radford, J., et al. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.99 · Cited by 16
Self-citationEngels, N., Riphagen, J. M., Egroo, M. V., Koops, E. A., Smegal, L. F., Becker, J. A., Prokopiou, P. C., Bueichekú, E., Kwong, K. K., Rentz, D. M., et al. (2024) · Annals of Neurology · doi:10.1002/ana.27022 · Cited by 19
Medial temporal tau predicts memory decline in cognitively unimpaired elderly
Kwan, A. T. H., Arfaie, S., Therriault, J., Azizi, Z., Lussier, F. Z., Tissot, C., Chamoun, M., Bezgin, G., Servaes, S., Stevenon, J., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac325 · Cited by 15
Harnessing cognitive trajectory clusterings to examine subclinical decline risk factors
Du, L., Hermann, B. P., Jonaitis, E. M., Cody, K. A., Rivera‐Rivera, L. A., Rowley, H. A., Field, A. S., Eisenmenger, L. B., Christian, B. T., Betthauser, T. J., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad333 · Cited by 15
Hallmarks of healthy cognitive aging: Inter-individual differences in aging trajectories
Abrous, D. N., Blin, N., Boraxbekk, C., Catheline, G., Fitzsimons, C. P., Hilscher, M. M., Lemoine, M., Lopes, L. V., Maass, A., Nilsson, M., et al. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103102 · Cited by 18
Wang, X., Sundermann, E. E., Buckley, R. F., Banks, S. J., & the A4 Study Team (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13432 · Cited by 14
Pudumjee, S. B., Lundt, E. S., Albertson, S. M., Machulda, M. M., Kremers, W. K., Jack, C. R., Knopman, D. S., Petersen, R. C., Mielke, M. M., & Stricker, N. H. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210251 · Cited by 13
Self-citationQin, S., Ng, K. K., Soon, C. S., Chua, X. Y., Zhou, J. H., Koh, W., & Chee, M. W. L. (2025) · Sleep Medicine · doi:10.1016/j.sleep.2025.106569 · Cited by 12
Recent advances in understanding Alzheimer’s Disease: diagnosis and management strategies
Marín, A., & Budson, A. E. (2023) · Faculty Reviews · doi:10.12703/r/12-24 · Cited by 12
Martins, D. R., Sha, F., der Elst, W. V., Shih, P., Devoght, J., Kolen, K. V., Mercken, M. H., Broeck, B. V., Declerck, P. J., & Theunis, C. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.101158 · Cited by 11
Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer’s disease
Ramanan, V. K., Heckman, M. G., Lesnick, T. G., Przybelski, S. A., Cahn, E. J., Kosel, M., Murray, M. E., Mielke, M. M., Botha, H., Graff‐Radford, J., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02419-2 · Cited by 10
Self-citationExploring discordant low amyloid beta and high neocortical tau positron emission tomography cases
Krishnadas, N., Doré, V., Laws, S. M., Porter, T., Lamb, F., Bozinovski, S., Villemagne, V. L., & Rowe, C. C. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12326 · Cited by 10
Li, W., Zhou, J., Li, S., Wu, M., Zhu, Y., Chen, Q., Chen, F., Ma, X., Zhang, X., Wang, Z., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1502171 · Cited by 9
Sleep and Tau Pathology in Vietnam War Veterans with Preclinical and Prodromal Alzheimer’s Disease
Andrews, M., Ross, R., Malhotra, A., Ancoli‐Israel, S., Brewer, J. B., Banks, S. J., & Initiative, A. D. N. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200245 · Cited by 10
Chen, Z., Gan, J., Yang, Y., Meng, Q., Han, J., & Ji, Y. (2022) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5683 · Cited by 11
Plasma NfL is associated with mild cognitive decline in patients with diabetes
Marutani, N., Akamine, S., Kanayama, D., Gotoh, S., Yanagida, K., Maruyama, R., Mori, K., Miyamoto, T., Adachi, H., Sakagami, Y., et al. (2022) · Psychogeriatrics · doi:10.1111/psyg.12819 · Cited by 9
Ramanan, V. K., Heckman, M. G., Przybelski, S. A., Lesnick, T. G., Lowe, V. J., Graff‐Radford, J., Mielke, M. M., Jack, C. R., Knopman, D. S., Petersen, R. C., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220164 · Cited by 9
Self-citationWeigand, A. J., Ortiz, G., Walker, K. S., Galasko, D. R., Bondi, M. W., & Thomas, K. R. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.10.016 · Cited by 10
Giuffrè, G. M., Quaranta, D., Citro, S., Morganti, T. G., Martellacci, N., Vita, M. G., Rossini, P. M., Calabresi, P., & Marra, C. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240150 · Cited by 8
Kim, C. M., Diez, I. P., Bueichekú, E., Ahn, S., Montal, V., & Sepulcre, J. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0488-23.2023 · Cited by 7
Terrera, G. M., Harrison, J., Ritchie, C. W., & Ritchie, K. A. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191108 · Cited by 8
Pathological correlates of impaired self-awareness of memory function in Alzheimer’s disease
Gagliardi, G. P., Kuppe, M. K., Lois, C., Hanseeuw, B. J., Vannini, P., & Initiative, A. D. N. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00856-x · Cited by 8
McVea, A. K., DiFilippo, A. H., McLachlan, M., Zammit, M. D., Bendlin, B. B., Johnson, S. C., Betthauser, T. J., & Christian, B. T. (2024) · Imaging Neuroscience · doi:10.1162/imag_a_00135 · Cited by 7
Interactive Effects of Pulse Pressure and Tau Imaging on Longitudinal Cognition
Weigand, A. J., Initiative, A. D. N., Macomber, A. J., Walker, K. S., Edwards, L., Thomas, K. R., Bangen, K. J., Nation, D. A., & Bondi, M. W. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220026 · Cited by 7
MRI-free processing of tau PET images for early detection
Carlson, M. L., Smith, V., Johns, E., Young, C. B., Vossler, H. A., Ward, T. J., Harrison, T. M., Tosun, D., Hohman, T. J., Landau, S. M., et al. (2024) · Imaging Neuroscience · doi:10.1162/imag_a_00369 · Cited by 6
Wu, J., Geng, C., Liu, L., & Tang, Y. (2025) · Medicine Plus · doi:10.1016/j.medp.2025.100112 · Cited by 8
Molinare, C. P., Soberanes, D., Dubbelman, M. A., Hsieh, S., Johnson, K. A., Rentz, D. M., Sperling, R. A., Marshall, G. A., Amariglio, R. E., Papp, K. V., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70047 · Cited by 5
Sheng, J., Trelle, A. N., Romero, A., Park, J., Tran, T., Sha, S. J., Andreasson, K. I., Wilson, E. N., Mormino, E. C., & Wagner, A. D. (2025) · Science Advances · doi:10.1126/sciadv.ads4206 · Cited by 9
Bhattarai, A., Holy, E. N., Wang, Y., Spencer, B. A., Wang, G., DeCarli, C. S., & Fan, A. P. (2025) · EJNMMI Research · doi:10.1186/s13550-025-01260-4 · Cited by 4
Zinkunegi, A. J., Betthauser, T. J., Carlsson, C. M., Bendlin, B. B., Okonkwo, O. C., Chin, N. A., Asthana, S., Langhough, R. E., Johnson, S. C., Mueller, K. D., et al. (2025) · Cortex · doi:10.1016/j.cortex.2024.12.012 · Cited by 4
Zhang, R., Initiative, A. D. N., Chen, S.-D., Shen, X., Yang, Y., Lu, J., Cui, M., Zuo, C., Dong, Q., Tan, L., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200526 · Cited by 4
Landau, S. M., Liu, P., Harrison, T. M., Taggett, J. Z., Ward, T. J., Murphy, A., Lockhart, S. N., Lovato, L., Koeppe, R., Farias, S. T., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71472 · Cited by 3
Self-citationDubbelman, M. A., Diez, I. P., Gonzalez, C., Amariglio, R. E., Becker, J. A., Chhatwal, J. P., Gatchel, J. R., Johnson, K. A., Locascio, J. J., Udeogu, O. J., et al. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1420290 · Cited by 3
Identifying cognitive test scores associated with early tau burden in Alzheimer's disease
Terao, C. M., Alexander, M. W., Chalmers, R. P., Boshmaf, S. Z., Paterson, J., Black, S. E., Papp, K. V., Sperling, R. A., & Rabin, J. S. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70052 · Cited by 3
Preclinical detection of Alzheimer’s disease pathology using conceptual discrimination abilities
Huyghe, L., Salman, Y., Colmant, L., Gérard, T., Malotaux, V., Besson, G., Delhaye, E., Bastin, C., Dessain, Q., Dricot, L., et al. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100332 · Cited by 2
Li, W., Zhang, S., Fan, W., Fu, X., Zhang, D., & Wen, L. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1463156 · Cited by 2
Trelle, A. N., Cody, K. A., Nguyen, T. T., Winer, J. R., Weiss, S., Sai, I., Channappa, D., Mendiola, J., Al-Rajhi, A., Raghuraman, K., et al. (2025) · medRxiv · doi:10.1101/2025.10.22.25338569 · Cited by 2
Glaubitz, E., Wang, X. H., Xi, K., Feiz, F., Pahlajani, S. S., Maloney, T., Tanzi, E. B., Hojjati, H., Zhou, L., Glodzik, L., et al. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115889 · Cited by 2
Spatiotemporal characterization of Alzheimer disease pathology in living human brain tissue
Aslanyan, A., Mukherjee, S., Moncur, E. M., Szadziewska, A., He, Y., Kac, P. R., Coyle, R. A., Camporesi, E., Sato, C., Ghoshal, N., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-76494-4 · Cited by 1
Li, Y., Kang, J., Wu, C., Dinov, I. D., Hu, J., Chalise, P., Mahnken, J. D., & Initiative, A. D. N. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.29.454368 · Cited by 1
Effects of Aducanumab on treating Alzheimer’s disease: targets and clinical trials
Huang, B. (2022) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v6i.973
Wang, S., Initiative, A. D. N., Liu, S., Ke, S., Zhou, W., & Pan, T. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230437 · Cited by 1
Bhattarai, A., Holy, E. N., Wang, Y., Spencer, B. A., Wang, G., DeCarli, C. S., & Fan, A. P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.02.601764
Trelle, A. N., Sheng, J., Wilson, E. N., Romero, A., Park, J., Deutsch, G. K., Sha, S. J., Greicius, M. D., Andreasson, K. I., Kerchner, G. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.20.660774
Association of Plasma p-tau181 and Cognition in Nondemented Subjects Without Aβ42/40 Positivity
Aw, T. B. H., Leow, Y. J., & Kandiah, N. (2025) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2025.06.017
黑, 君. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1582260
Seo, E. H., Lim, H. J., Yoon, H.-J., Choi, K. Y., Lee, J. J., Park, J. Y., Choi, S. H., Kim, H., Kim, B. C., & Lee, K. H. (2021) · Figshare · doi:10.6084/m9.figshare.16779366
Tsoy, E., Strom, A., Iaccarino, L., Erlhoff, S. J., Goode, C. A., Rodriguez, A.-M., Rabinovici, G. D., Miller, B. L., Kramer, J. H., Rankin, K. P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13787218
Additional file 1 of APOE effects on regional tau in preclinical Alzheimer’s disease
Young, C. B., Johns, E., Kennedy, G., Belloy, M. E., Insel, P. S., Greicius, M. D., Sperling, R. A., Johnson, K. A., Poston, K. L., & Mormino, E. C. (2023) · Figshare · doi:10.6084/m9.figshare.22608413
Additional file 3 of Mesial temporal tau in amyloid-β-negative cognitively normal older persons
Krishnadas, N., Doré, V., Groot, C., Lamb, F., Bourgeat, P., Burnham, S. C., Huang, K., Goh, A. M. Y., Masters, C. L., Villemagne, V. L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19565845
Additional file 5 of Mesial temporal tau in amyloid-β-negative cognitively normal older persons
Krishnadas, N., Doré, V., Groot, C., Lamb, F., Bourgeat, P., Burnham, S. C., Huang, K., Goh, A. M. Y., Masters, C. L., Villemagne, V. L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19565851
Additional file 2 of Mesial temporal tau in amyloid-β-negative cognitively normal older persons
Krishnadas, N., Doré, V., Groot, C., Lamb, F., Bourgeat, P., Burnham, S. C., Huang, K., Goh, A. M. Y., Masters, C. L., Villemagne, V. L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19565842
Additional file 1 of Mesial temporal tau in amyloid-β-negative cognitively normal older persons
Krishnadas, N., Doré, V., Groot, C., Lamb, F., Bourgeat, P., Burnham, S. C., Huang, K., Goh, A. M. Y., Masters, C. L., Villemagne, V. L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19565839
Additional file 4 of Mesial temporal tau in amyloid-β-negative cognitively normal older persons
Krishnadas, N., Doré, V., Groot, C., Lamb, F., Bourgeat, P., Burnham, S. C., Huang, K., Goh, A. M. Y., Masters, C. L., Villemagne, V. L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19565848
Metadata
- Authors
- Lowe, V. J., Bruinsma, T. J., Wiste, H. J., Min, H.-K., Weigand, S. D., Fang, P., Senjem, M. L., Therneau, T. M., Boeve, B. F., Josephs, K. A., Pandey, M. K., Murray, M. E., Kantarci, K., Jones, D. T., Vemuri, P., Graff-Radford, J., Schwarz, C. G., Machulda, M. M., Mielke, M. M., Roberts, R. O., Knopman, D. S., Petersen, R. C., & Jack, C. R.
- Affiliations
- From the Departments of Radiology (V.J.L., T.J.B., H.-K.M., P.F., M.L.S., M.K.P., K.K., D.T.J., P.V., C.G.S., C.R.J.), Health Sciences Research (H.J.W., S.D.W., T.M.T., M.M. Mielke, R.O.R.), Information Technology (M.L.S.), Neurology (B.F.B., K.A.J., D.T.J., J.G.-R., M.M. Mielke, D.S.K., R.C.P.), Neuroscience (M.E.M.), and Psychiatry and Psychology (M.M. Machulda), Mayo Clinic, Rochester, MN.
- ORCID
- Lowe, Val J.
- Bruinsma, Tyler J.
- Wiste, Heather J.
- Min, Hoon-Ki
- Weigand, Stephen D.
- Fang, Ping
- Senjem, Matthew L.
- Therneau, Terry M.
- Boeve, Bradley F.
- Josephs, Keith A.
- Pandey, Mukesh K.
- Murray, Melissa E.
- Kantarci, Kejal
- Jones, David T.
- Vemuri, Prashanthi
- Schwarz, Christopher G.
- Machulda, Mary M.
- Mielke, Michelle M.
- Knopman, David S.
- Petersen, Ronald C.
- Jack, Clifford R.
- Venue
- Neurology
- Published
- 2019-07-02
- Volume
- 93
- Issue
- 1
- Pages
- e29-e39
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC6659005
- OpenAlex
- W2947200125
- Cited by
- 107
- References
- 50
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 13 · 2023: 15 · 2022: 23 · 2021: 19 · 2020: 11 · 2019: 4
- FWCI
- 11.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic
- Pfizer
- Biogen
- Mayo Foundation for Medical Education and Research
- National Institutes of Health
- Genentech
- Avid Radiopharmaceuticals
- National Institute on Aging (U01AG006786, R01AG011378, RF1AG057547, R01AG041851, R37AG011378, P50AG016574)
- National Institute on Deafness and Other Communication Disorders (R01DC010367)
- National Institute of Neurological Disorders and Stroke (R01NS089544, R21NS094489, R01NS089757, R01NS097495)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- tau PET, neurofibrillary tangles, cognitive performance, memory performance, entorhinal cortex, medial temporal lobe, amyloid PET, standardized uptake value ratio, language performance, Mayo Clinic Study of Aging
- MeSH terms
- Aged, Aged, 80 and over, Amyloid, Brain, Cognition, Cross-Sectional Studies, Female, Humans, Male, Memory, Middle Aged, Cohort Studies, tau Proteins, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
